Sensorium Therapeutics Announces Appointment of Veteran Biotech Executive Alexandra Glucksmann, Ph.D., as CEO as the Company Progresses Toward the Clinic
Company
Sensorium Therapeutics
BostonHealthcareHealth CareDescription
Sensorium Therapeutics , a biotechnology company leveraging machine learning, medicinal chemistry and neuroscience to develop nature-inspired psychoactive medicines for mental health, today announced its incoming Chief Executive Officer. Sensorium welcomed Alexandra Glucksmann, Ph.D., as CEO and President, as former CEO and Co-founder, Dick Simon, transitions to an advisory role while continuing to serve on the Board of Directors.
Who to call at Sensorium Therapeutics, and when
A new leader at Sensorium Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Sensorium Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sensorium Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sensorium Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sensorium Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sensorium Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.